BOSTON--(BUSINESS WIRE)--Health Connexions™ is announcing a strategic alliance with Tekcapital plc (AIM: TEK), an international provider of technology and intellectual property services, to provide the Invention Evaluator service to the Health Connexions network of over 5 million contacts in life sciences, health care and consumer health.
Invention Evaluator, a Tekcapital company, provides in-depth analytical reports that assess the commercial potential of new technologies and intellectual property, thereby enabling clients to make more informed decisions about their potential investments in those technologies. The expert analysts at Invention Evaluator have completed over 4000 reports in the last 5 years, and as part of the new alliance, Health Connexions™ will now make the Invention Evaluator reports available to its clients and network members worldwide.
Commenting on the announcement, Dr. Clifford Gross, Executive Chairman of Tekcapital plc said, “The acquisition of Invention Evaluator has expanded our service offering and client base. To further expand its market penetration into life science and health care companies, we are very excited to have entered into a strategic alliance with Health Connexions™. We believe their large network of leading companies, focused on improving medical outcomes, is an excellent fit with Invention Evaluator’s reports, which provide guidance on the marketability of newly developed technologies.”
Invention Evaluator accelerates the process to commercialization by providing unbiased feedback in the form of an analyst report on the technology landscape, intellectual property, and commercial potential of the invention. The report provides vital information about the strengths, weaknesses, opportunities and threats to take into consideration if you choose to move forward. And, it provides a clear strategy and information resources to guide the next steps.
This service is disruptive because it provides an objective source of information, based on analysts that are Subject Matter Experts, who utilize a proprietary process to enhance accuracy, relevance and actionability from the report. Consequently, the Invention Evaluator is re-writing the rules on business planning because it evaluates and answers the pertinent questions for just $995 USD, and provides the report back in only 10 business days.
Commenting on the announcement, Dawn Van Dam, President & CEO of Health Connexions™ said, “We have a strategic mandate to accelerate the evaluation, validation and adoption of the best solutions in life sciences and health care. Therefore, we were quick to identify the potential of the Invention Evaluator to provide unprecedented value to our clients and connections around the world. Our goal is to transform science into commercial success. Therefore, we believe that Invention Evaluator’s comprehensive and cost-effective reports, which assess the marketability of new technologies, should prove quite valuable to many of our clients.”
Through the proprietary Invention Evaluator process, the analysts assess an idea or invention in a systematic way and look at the technical merits and challenges, the intellectual property that may be protectable, and the commercial potential of the invention. Contact us today to learn more, and begin your path to the successful commercialization of the right opportunities for your organization.
About Health Connexions, Inc. – Transforming Science into Commercial Success
Health Connexions™ works to accelerate the evaluation, validation and commercialization of new technologies in life sciences, health care and consumer health by providing services in consulting & market research, technology evaluations and marketing communications. With an extensive network of over 5 million contacts, clients can profit from these connections and expertise garnered over the last 15 years. Health Connexions also provides strategic advisory services around raising capital to fund new opportunities, or to support the growth of established organizations, by connecting capital and science to optimize ROI. For more information, please visit www.healthconnexions.com
About Tekcapital plc - The World’s Largest University Network for Open Innovation
Tekcapital helps clients profit from new, university-developed intellectual properties. With our proprietary discovery search engine, linked to 4,000 universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP they need to create a competitive advantage. Tekcapital plc is listed on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com